| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13591* | 2021 |
| Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer A Ward, A Balwierz, JD Zhang, M Küblbeck, Y Pawitan, T Hielscher, ... Oncogene 32 (9), 1173-1182, 2013 | 340 | 2013 |
| MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways I Keklikoglou, C Koerner, C Schmidt, JD Zhang, D Heckmann, ... Oncogene 31 (37), 4150-4163, 2012 | 332 | 2012 |
| Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor α in breast cancer cells P de Souza Rocha Simonini, A Breiling, N Gupta, M Malekpour, M Youns, ... Cancer research 70 (22), 9175-9184, 2010 | 324 | 2010 |
| MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F S Jurmeister, M Baumann, A Balwierz, I Keklikoglou, A Ward, S Uhlmann, ... Molecular and cellular biology 32 (3), 633-651, 2012 | 296 | 2012 |
| Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer O Saatci, A Kaymak, U Raza, PG Ersan, O Akbulut, CE Banister, ... Nature communications 11 (1), 2416, 2020 | 260 | 2020 |
| miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer S Uhlmann, JD Zhang, A Schwäger, H Mannsperger, Y Riazalhosseini, ... Oncogene 29 (30), 4297-4306, 2010 | 260 | 2010 |
| Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancer S Uhlmann, H Mannsperger, JD Zhang, EÁ Horvat, C Schmidt, ... Molecular systems biology 8 (1), 570, 2012 | 243 | 2012 |
| Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance Ö Sahin, H Fröhlich, C Löbke, U Korf, S Burmester, M Majety, J Mattern, ... BMC systems biology 3, 1-20, 2009 | 243 | 2009 |
| 14-3-3ζ turns TGF-β’s function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2 J Xu, S Acharya, O Sahin, Q Zhang, Y Saito, J Yao, H Wang, P Li, L Zhang, ... Cancer cell 27 (2), 177-192, 2015 | 197 | 2015 |
| Localization‐and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32. 31 F Haller, A Von Heydebreck, JD Zhang, B Gunawan, C Langer, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 156 | 2010 |
| miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance M Mutlu, U Raza, Ö Saatci, E Eyüpoğlu, E Yurdusev, Ö Şahin Journal of Molecular Medicine 94, 629-644, 2016 | 147 | 2016 |
| MicroRNA‐519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour‐suppressor genes in ER+ breast cancer A Ward, K Shukla, A Balwierz, Z Soons, R König, Ö Sahin, S Wiemann The Journal of pathology 233 (4), 368-379, 2014 | 135 | 2014 |
| Polyol pathway links glucose metabolism to the aggressiveness of cancer cells A Schwab, A Siddiqui, ME Vazakidou, F Napoli, M Böttcher, B Menchicchi, ... Cancer research 78 (7), 1604-1618, 2018 | 114 | 2018 |
| MicroRNAs: master regulators of drug resistance, stemness, and metastasis U Raza, JD Zhang, Ö Şahin Journal of molecular medicine 92, 321-336, 2014 | 92 | 2014 |
| Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models A Issa, JW Gill, MR Heideman, O Sahin, S Wiemann, JH Dey, NE Hynes Breast Cancer Research 15, 1-16, 2013 | 86 | 2013 |
| Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler H Bergholtz, JM Carter, A Cesano, MCU Cheang, SE Church, P Divakar, ... Cancers 13 (17), 4456, 2021 | 77 | 2021 |
| Oncogenic kinase–induced PKM2 tyrosine 105 phosphorylation converts nononcogenic PKM2 to a tumor promoter and induces cancer stem–like cells Z Zhou, M Li, L Zhang, H Zhao, Ö Şahin, J Chen, JJ Zhao, Z Songyang, ... Cancer research 78 (9), 2248-2261, 2018 | 77 | 2018 |
| Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer Ö Saatci, S Borgoni, Ö Akbulut, S Durmuş, U Raza, E Eyüpoğlu, C Alkan, ... Oncogene 37 (17), 2251-2269, 2018 | 74 | 2018 |
| Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies O Saatci, KT Huynh-Dam, O Sahin Journal of Molecular Medicine 99 (12), 1691-1710, 2021 | 73 | 2021 |
